You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 4, April 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 •eFigures
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Lung Cancer
 •Oncology, Other
 •Ocular/ Adnexal Tumors
 •Uveitis
 •Pulmonary Diseases
 •Pulmonary Diseases, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pulmonary Metastasis Masquerading as Anterior Uveitis

Muge R. Kesen, MD; Deepak P. Edward, MD; Lawrence J. Ulanski, MD; Howard H. Tessler, MD; Debra A. Goldstein, MD

Arch Ophthalmol. 2008;126(4):572-574.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Uveal metastasis is the most common intraocular malignancy,1 but iris involvement accounts for only 5% to 10% of cases.2-3 Most iris metastases are carcinomas, with breast, lung, and gastrointestinal tract carcinomas representing the majority of primary tumors. Renal cell carcinoma is also reported to result in metastasis to the iris.4 There is no history of a previously diagnosed primary tumor in 32% of cases.3 We report a case in which an iris lesion led to the detection of lung cancer.

Report of a Case

A 65-year-old white woman noted pain in her left eye, was diagnosed with anterior uveitis, and was treated with topical steroid drops. Two weeks later an iris mass was noted. The mass enlarged during a 2-week period, resulting in her referral to the University of Illinois at Chicago.

Her ocular . . . [Full Text of this Article]


Comment

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Preenucleation Radiotherapy, Uveal Melanoma, and Competing Risks—Reply
Emine Kilic, Theo Stijnen, and Gre P. M. Luyten
Arch Ophthalmol. 2008;126(4):581-582.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.